<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-140929</identifier>
<setSpec>0214-3429</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Filamentous fungal infections in immunosup - pressed patients: prophylaxis and treatment</dc:title>
<dc:description xml:lang="en">Although the incidence of invasive aspergillosis has decreased in haematologic patients and solid organ transplant recipients due to the use of prophylaxis; aspergillosis has emerged in other populations undergoing immunosuppressive drugs where prophylaxis is not well defined presenting different clinical patterns. Voriconazole is the gold standard in the treatment of aspergillosis and probably combined therapy, with voriconazole plus anidulafungin, could have a role in the initial management of the infection (AU)</dc:description>
<dc:creator>Ruiz-Camps, Isabel</dc:creator>
<dc:creator>Peghin, Maddalena</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Aunque ha disminuido la incidencia de aspergilosis invasora en pacientes hematológicos y en receptores de  trasplante de órgano sólido con el uso de profilaxis,  esta infección ha aumentado en otras poblaciones sometidas a tratamientos inmunosupresores donde la prevención no está bien definida. Además, en estos pacientes se presentan  formas clínicas diferentes. Voriconazol constituye el tratamiento de elección de la aspergilosis invasora aunque la terapia combinada de voriconazol con anidulafungina podría tener su papel en las fases iniciales de la infección (AU)</dc:description>
<dc:source>Rev Esp Quimioter;28(supl.1): 38-42, sept. 2015. tab, ilus</dc:source>
<dc:identifier>ibc-140929</dc:identifier>
<dc:title xml:lang="es">Infecciones por hongos filamentosos en el pacient inmunosuprimido: profilaxis y tratamiento</dc:title>
<dc:subject>^d30037^s22045</dc:subject>
<dc:subject>^d30037^s22066</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d5794^s22001</dc:subject>
<dc:subject>^d32857^s22039</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1235^s22016</dc:subject>
<dc:subject>^d1235^s22057</dc:subject>
<dc:subject>^d14575^s22045</dc:subject>
<dc:subject>^d32857^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d55600^s22073</dc:subject>
<dc:subject>^d5794^s22052</dc:subject>
<dc:subject>^d32857^s22045</dc:subject>
<dc:subject>^d1235^s22054</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:subject>^d30040^s22038</dc:subject>
<dc:subject>^d1235^s22080</dc:subject>
<dc:subject>^d29431^s22045</dc:subject>
<dc:subject>^d30040^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>201509</dc:date>
</metadata>
</record>
</ibecs-document>
